JP, S., J, M., N, S., & JC, W. (2019). Cancer therapy-induced cardiomyopathy: Can human induced pluripotent stem cell modelling help prevent it? European heart journal, 40(22), 1764. https://doi.org/10.1093/eurheartj/ehx811
Chicago Style (17th ed.) CitationJP, Stack, Moslehi J, Sayed N, and Wu JC. "Cancer Therapy-induced Cardiomyopathy: Can Human Induced Pluripotent Stem Cell Modelling Help Prevent It?" European Heart Journal 40, no. 22 (2019): 1764. https://doi.org/10.1093/eurheartj/ehx811.
MLA (9th ed.) CitationJP, Stack, et al. "Cancer Therapy-induced Cardiomyopathy: Can Human Induced Pluripotent Stem Cell Modelling Help Prevent It?" European Heart Journal, vol. 40, no. 22, 2019, p. 1764, https://doi.org/10.1093/eurheartj/ehx811.
Warning: These citations may not always be 100% accurate.